173 related articles for article (PubMed ID: 32641384)
1. The Role of Autoimmunity-Related Gene
Rijvers L; Melief MJ; van Langelaar J; van der Vuurst de Vries RM; Wierenga-Wolf AF; Koetzier SC; Priatel JJ; Jorritsma T; van Ham SM; Hintzen RQ; van Luijn MM
J Immunol; 2020 Aug; 205(4):945-956. PubMed ID: 32641384
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis-associated CLEC16A controls HLA class II expression via late endosome biogenesis.
van Luijn MM; Kreft KL; Jongsma ML; Mes SW; Wierenga-Wolf AF; van Meurs M; Melief MJ; der Kant Rv; Janssen L; Janssen H; Tan R; Priatel JJ; Neefjes J; Laman JD; Hintzen RQ
Brain; 2015 Jun; 138(Pt 6):1531-47. PubMed ID: 25823473
[TBL] [Abstract][Full Text] [Related]
3. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
5. Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
van Luijn MM; Chamuleau ME; Ressing ME; Wiertz EJ; Ostrand-Rosenberg S; Souwer Y; Zevenbergen A; Ossenkoppele GJ; van de Loosdrecht AA; van Ham SM
Cancer Immunol Immunother; 2010 Dec; 59(12):1825-38. PubMed ID: 20820776
[TBL] [Abstract][Full Text] [Related]
6. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
[TBL] [Abstract][Full Text] [Related]
7. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
9. Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells.
Copier J; Potter P; Sacks SH; Kelly AP
Immunology; 1998 Apr; 93(4):505-10. PubMed ID: 9659222
[TBL] [Abstract][Full Text] [Related]
10. DR/CLIP (class II-associated invariant chain peptides) and DR/peptide complexes colocalize in prelysosomes in human B lymphoblastoid cells.
Stang E; Guerra CB; Amaya M; Paterson Y; Bakke O; Mellins ED
J Immunol; 1998 May; 160(10):4696-707. PubMed ID: 9590215
[TBL] [Abstract][Full Text] [Related]
11. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
12. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
Moldenhauer G; Henne C; Karhausen J; Möller P
Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
[TBL] [Abstract][Full Text] [Related]
13. H2-Mbeta 1 and H2-Mbeta 2 heterodimers equally promote clip removal in I-A(q) molecules from autoimmune-prone DBA/1 mice.
Walter W; Scheuer C; Loos M; Reichert TE; Maeurer MJ
J Biol Chem; 2001 Apr; 276(14):11086-91. PubMed ID: 11148202
[TBL] [Abstract][Full Text] [Related]
14. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
[TBL] [Abstract][Full Text] [Related]
15. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
16. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
Hammond C; Denzin LK; Pan M; Griffith JM; Geuze HJ; Cresswell P
J Immunol; 1998 Oct; 161(7):3282-91. PubMed ID: 9759843
[TBL] [Abstract][Full Text] [Related]
17. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
[TBL] [Abstract][Full Text] [Related]
18. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR peptide occupancy can be regulated with a wide variety of small molecules.
Blazekovic F; Odukoya D; Butler SN; Mauro JA; Ramsamooj M; Puleo E; Szekeres K; Dana D; Kumar S; Ragupathi G; Blanck G
Hum Vaccin Immunother; 2016 Mar; 12(3):593-8. PubMed ID: 26453454
[TBL] [Abstract][Full Text] [Related]
20. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
